Renova Therapeutics
PrivateLast Round
Grant
Jun 1, 2022
Total Funding Raised
$9.12M
Company Overview
Renova Therapeutics is a biotechnology company that develops definitive, one-time gene therapies to restore the health of people suffering from chronic diseases such as congestive heart failure and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renova Therapeutics Comparables
Compare Renova Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medera | 83% | |
| Bayer AG | 80% | |
| XyloCor Therapeutics | 77% | |
Renova Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 | ||||
| Grant | Feb 23, 2016 | ||||
| Series C | Sep 30, 2014 |
Key People
Founding team and executive leadership
Renova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| BioBrit | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2025
Monthly visitors grew 36% MoM, reaching 1.9K.
- May 2, 2025
Monthly visitors grew 33% MoM, reaching 1.6K.
Renova Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Renova Therapeutics's valuation, stock price, and market status.